Skip to main content
. 2020 Nov 10;21(22):8432. doi: 10.3390/ijms21228432
CoQ10 Coenzyme Q10
ADI Acceptable daily intake
NOAEL No-observed-adverse-effect level
UVB Ultraviolet B
CVD Diabetic cardiovascular disease
ROS Reactive oxygen species
RAGE Receptor for advanced glycation end products
AGEs Advanced glycation end products
NADPH Nicotinamide adenine dinucleotide phosphate
PKC Protein kinase C
DN Diabetic nephropathy
UTMD Ultrasound-targeted microbubble destruction
MSA Multiple system atrophy
CSF Cerebrospinal fluid
COQ2 Coenzyme Q2
COQ9 Coenzyme Q9
COQ8A Coenzyme Q8A
ETFDH Electron transfer flavoprotein dehydrogenase
PDSS2 Decaprenyl diphosphate synthase subunit 2
AIDS Acquired immune deficiency syndrome
CRP C-reactive protein
IL-6 Interleukin 6
TNF-α Tumor necrosis factor alpha
P-gp P-glycoprotein
TPGS α-tocopherol polyethylene glycol 1000 succinate
RGC Retinal ganglion cells
IOP Intraocular pressure
PD Parkinson disease
NF-β Nuclear factor beta
POPC Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
IMM Inner mitochondrial membrane
IIF Flavin site in complex II
FM Fibromyalgia
IL-1β Interleukin 1 beta
UV Ultraviolet
IL-18 Interleukin 18
FH Familial hypercholesterolemia
GIT Gastrointestinal tract
SNEDDS Self-nanoemulsifying drug delivery systems
HPH High-pressure homogenization
PHCO PEG40 hydrogenated castor oil
TPGS Tocopherol polyethylene glycol succinate
EC Ethyl cellulose
MCT Medium-chain triglyceride
SMS SMS detergent
CMC Critical micelle concentration
HMGCR 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase
LDL Low-density lipoprotein
LDL-R Low-density lipoprotein receptor
ACE Angiotensin-converting enzyme
CHF Chronic heart failure